nodes	percent_of_prediction	percent_of_DWPC	metapath
Temozolomide—melanoma—head and neck cancer	0.469	0.518	CtDrD
Temozolomide—skin cancer—head and neck cancer	0.436	0.482	CtDrD
Temozolomide—Embolism—Docetaxel—head and neck cancer	0.000576	0.00607	CcSEcCtD
Temozolomide—Hepatic failure—Hydroxyurea—head and neck cancer	0.000575	0.00606	CcSEcCtD
Temozolomide—Parosmia—Docetaxel—head and neck cancer	0.00057	0.00601	CcSEcCtD
Temozolomide—Herpes simplex—Fluorouracil—head and neck cancer	0.000556	0.00586	CcSEcCtD
Temozolomide—Interstitial lung disease—Docetaxel—head and neck cancer	0.000522	0.0055	CcSEcCtD
Temozolomide—Face oedema—Hydroxyurea—head and neck cancer	0.000499	0.00525	CcSEcCtD
Temozolomide—Scotoma—Docetaxel—head and neck cancer	0.000487	0.00513	CcSEcCtD
Temozolomide—Hepatotoxicity—Docetaxel—head and neck cancer	0.000479	0.00504	CcSEcCtD
Temozolomide—Otitis media—Docetaxel—head and neck cancer	0.000475	0.005	CcSEcCtD
Temozolomide—Breast disorder—Hydroxyurea—head and neck cancer	0.000467	0.00492	CcSEcCtD
Temozolomide—Pancytopenia—Vinblastine—head and neck cancer	0.000465	0.0049	CcSEcCtD
Temozolomide—Rigors—Docetaxel—head and neck cancer	0.000453	0.00477	CcSEcCtD
Temozolomide—Depression—Vinblastine—head and neck cancer	0.000435	0.00459	CcSEcCtD
Temozolomide—Thrombophlebitis—Fluorouracil—head and neck cancer	0.00043	0.00453	CcSEcCtD
Temozolomide—Neuropathy peripheral—Vinblastine—head and neck cancer	0.000428	0.00451	CcSEcCtD
Temozolomide—Pancytopenia—Hydroxyurea—head and neck cancer	0.000424	0.00447	CcSEcCtD
Temozolomide—Amenorrhoea—Docetaxel—head and neck cancer	0.000421	0.00443	CcSEcCtD
Temozolomide—Neutropenia—Hydroxyurea—head and neck cancer	0.000418	0.0044	CcSEcCtD
Temozolomide—Dysuria—Hydroxyurea—head and neck cancer	0.000418	0.0044	CcSEcCtD
Temozolomide—Hyperbilirubinaemia—Docetaxel—head and neck cancer	0.000407	0.00428	CcSEcCtD
Temozolomide—Weight increased—Hydroxyurea—head and neck cancer	0.000406	0.00428	CcSEcCtD
Temozolomide—Infestation NOS—Hydroxyurea—head and neck cancer	0.000398	0.00419	CcSEcCtD
Temozolomide—Infestation—Hydroxyurea—head and neck cancer	0.000398	0.00419	CcSEcCtD
Temozolomide—Amnesia—Fluorouracil—head and neck cancer	0.000396	0.00417	CcSEcCtD
Temozolomide—Haemoglobin—Vinblastine—head and neck cancer	0.000394	0.00415	CcSEcCtD
Temozolomide—Haemorrhage—Vinblastine—head and neck cancer	0.000392	0.00413	CcSEcCtD
Temozolomide—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.00039	0.00411	CcSEcCtD
Temozolomide—Hypoaesthesia—Vinblastine—head and neck cancer	0.00039	0.00411	CcSEcCtD
Temozolomide—Pharyngitis—Vinblastine—head and neck cancer	0.000389	0.0041	CcSEcCtD
Temozolomide—Hearing impaired—Docetaxel—head and neck cancer	0.000388	0.00409	CcSEcCtD
Temozolomide—Stomatitis—Hydroxyurea—head and neck cancer	0.000388	0.00409	CcSEcCtD
Temozolomide—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.000377	0.00397	CcSEcCtD
Temozolomide—Respiratory failure—Docetaxel—head and neck cancer	0.000377	0.00397	CcSEcCtD
Temozolomide—Pulmonary embolism—Docetaxel—head and neck cancer	0.00037	0.0039	CcSEcCtD
Temozolomide—Phosphatase alkaline increased—Docetaxel—head and neck cancer	0.00037	0.0039	CcSEcCtD
Temozolomide—Haemoglobin—Hydroxyurea—head and neck cancer	0.000359	0.00378	CcSEcCtD
Temozolomide—Influenza like illness—Docetaxel—head and neck cancer	0.000359	0.00378	CcSEcCtD
Temozolomide—Haemorrhage—Hydroxyurea—head and neck cancer	0.000357	0.00377	CcSEcCtD
Temozolomide—Hallucination—Hydroxyurea—head and neck cancer	0.000356	0.00375	CcSEcCtD
Temozolomide—Candida infection—Docetaxel—head and neck cancer	0.000353	0.00372	CcSEcCtD
Temozolomide—Skin exfoliation—Docetaxel—head and neck cancer	0.000353	0.00372	CcSEcCtD
Temozolomide—Ataxia—Fluorouracil—head and neck cancer	0.00035	0.00368	CcSEcCtD
Temozolomide—Neuropathy—Docetaxel—head and neck cancer	0.000347	0.00366	CcSEcCtD
Temozolomide—Alopecia—Vinblastine—head and neck cancer	0.000346	0.00365	CcSEcCtD
Temozolomide—Dry skin—Fluorouracil—head and neck cancer	0.000341	0.00359	CcSEcCtD
Temozolomide—Neoplasm—Docetaxel—head and neck cancer	0.000334	0.00352	CcSEcCtD
Temozolomide—Muscular weakness—Fluorouracil—head and neck cancer	0.000328	0.00346	CcSEcCtD
Temozolomide—Angiopathy—Hydroxyurea—head and neck cancer	0.000324	0.00342	CcSEcCtD
Temozolomide—Dysphagia—Fluorouracil—head and neck cancer	0.000321	0.00339	CcSEcCtD
Temozolomide—Chills—Hydroxyurea—head and neck cancer	0.000321	0.00338	CcSEcCtD
Temozolomide—Ill-defined disorder—Vinblastine—head and neck cancer	0.000317	0.00333	CcSEcCtD
Temozolomide—Alopecia—Hydroxyurea—head and neck cancer	0.000316	0.00333	CcSEcCtD
Temozolomide—Anaemia—Vinblastine—head and neck cancer	0.000315	0.00332	CcSEcCtD
Temozolomide—Erythema—Hydroxyurea—head and neck cancer	0.000311	0.00328	CcSEcCtD
Temozolomide—Thrombophlebitis—Docetaxel—head and neck cancer	0.00031	0.00327	CcSEcCtD
Temozolomide—Blood alkaline phosphatase increased—Docetaxel—head and neck cancer	0.000309	0.00325	CcSEcCtD
Temozolomide—Malaise—Vinblastine—head and neck cancer	0.000308	0.00324	CcSEcCtD
Temozolomide—Vertigo—Vinblastine—head and neck cancer	0.000307	0.00323	CcSEcCtD
Temozolomide—Leukopenia—Vinblastine—head and neck cancer	0.000305	0.00322	CcSEcCtD
Temozolomide—Pancytopenia—Fluorouracil—head and neck cancer	0.000305	0.00322	CcSEcCtD
Temozolomide—Deafness—Docetaxel—head and neck cancer	0.0003	0.00316	CcSEcCtD
Temozolomide—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.000299	0.00315	CcSEcCtD
Temozolomide—Hepatic failure—Docetaxel—head and neck cancer	0.000299	0.00315	CcSEcCtD
Temozolomide—Convulsion—Vinblastine—head and neck cancer	0.000296	0.00311	CcSEcCtD
Temozolomide—Hypertension—Vinblastine—head and neck cancer	0.000295	0.0031	CcSEcCtD
Temozolomide—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.000293	0.00309	CcSEcCtD
Temozolomide—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.000289	0.00304	CcSEcCtD
Temozolomide—Pneumonia—Fluorouracil—head and neck cancer	0.000288	0.00304	CcSEcCtD
Temozolomide—Anaemia—Hydroxyurea—head and neck cancer	0.000288	0.00303	CcSEcCtD
Temozolomide—Discomfort—Vinblastine—head and neck cancer	0.000287	0.00302	CcSEcCtD
Temozolomide—Hot flush—Docetaxel—head and neck cancer	0.000287	0.00302	CcSEcCtD
Temozolomide—Infestation NOS—Fluorouracil—head and neck cancer	0.000287	0.00302	CcSEcCtD
Temozolomide—Infestation—Fluorouracil—head and neck cancer	0.000287	0.00302	CcSEcCtD
Temozolomide—Menopausal symptoms—Docetaxel—head and neck cancer	0.000284	0.003	CcSEcCtD
Temozolomide—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.000281	0.00296	CcSEcCtD
Temozolomide—Malaise—Hydroxyurea—head and neck cancer	0.000281	0.00296	CcSEcCtD
Temozolomide—Stomatitis—Fluorouracil—head and neck cancer	0.000279	0.00294	CcSEcCtD
Temozolomide—Urinary tract infection—Fluorouracil—head and neck cancer	0.000279	0.00293	CcSEcCtD
Temozolomide—Leukopenia—Hydroxyurea—head and neck cancer	0.000279	0.00293	CcSEcCtD
Temozolomide—Thrombocytopenia—Vinblastine—head and neck cancer	0.000273	0.00287	CcSEcCtD
Temozolomide—Convulsion—Hydroxyurea—head and neck cancer	0.00027	0.00284	CcSEcCtD
Temozolomide—Sinusitis—Fluorouracil—head and neck cancer	0.000269	0.00283	CcSEcCtD
Temozolomide—Anorexia—Vinblastine—head and neck cancer	0.000265	0.0028	CcSEcCtD
Temozolomide—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.000263	0.00277	CcSEcCtD
Temozolomide—Discomfort—Hydroxyurea—head and neck cancer	0.000262	0.00276	CcSEcCtD
Temozolomide—Haemoglobin—Fluorouracil—head and neck cancer	0.000259	0.00272	CcSEcCtD
Temozolomide—Haemorrhage—Fluorouracil—head and neck cancer	0.000257	0.00271	CcSEcCtD
Temozolomide—Hypoaesthesia—Fluorouracil—head and neck cancer	0.000256	0.0027	CcSEcCtD
Temozolomide—Pharyngitis—Fluorouracil—head and neck cancer	0.000255	0.00269	CcSEcCtD
Temozolomide—Oedema—Hydroxyurea—head and neck cancer	0.000254	0.00268	CcSEcCtD
Temozolomide—Ataxia—Docetaxel—head and neck cancer	0.000252	0.00266	CcSEcCtD
Temozolomide—Infection—Hydroxyurea—head and neck cancer	0.000252	0.00266	CcSEcCtD
Temozolomide—Paraesthesia—Vinblastine—head and neck cancer	0.00025	0.00263	CcSEcCtD
Temozolomide—Dehydration—Docetaxel—head and neck cancer	0.00025	0.00263	CcSEcCtD
Temozolomide—Nervous system disorder—Hydroxyurea—head and neck cancer	0.000249	0.00262	CcSEcCtD
Temozolomide—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.000249	0.00262	CcSEcCtD
Temozolomide—Skin disorder—Hydroxyurea—head and neck cancer	0.000247	0.0026	CcSEcCtD
Temozolomide—Dry skin—Docetaxel—head and neck cancer	0.000246	0.00259	CcSEcCtD
Temozolomide—Breast disorder—Docetaxel—head and neck cancer	0.000243	0.00256	CcSEcCtD
Temozolomide—Anorexia—Hydroxyurea—head and neck cancer	0.000242	0.00255	CcSEcCtD
Temozolomide—Decreased appetite—Vinblastine—head and neck cancer	0.000242	0.00255	CcSEcCtD
Temozolomide—Toxic epidermal necrolysis—Docetaxel—head and neck cancer	0.000242	0.00255	CcSEcCtD
Temozolomide—Aspartate aminotransferase increased—Docetaxel—head and neck cancer	0.000242	0.00255	CcSEcCtD
Temozolomide—Pain—Vinblastine—head and neck cancer	0.000238	0.00251	CcSEcCtD
Temozolomide—Constipation—Vinblastine—head and neck cancer	0.000238	0.00251	CcSEcCtD
Temozolomide—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.000237	0.00249	CcSEcCtD
Temozolomide—Dysphagia—Docetaxel—head and neck cancer	0.000232	0.00244	CcSEcCtD
Temozolomide—Feeling abnormal—Vinblastine—head and neck cancer	0.000229	0.00242	CcSEcCtD
Temozolomide—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000228	0.0024	CcSEcCtD
Temozolomide—Alopecia—Fluorouracil—head and neck cancer	0.000227	0.00239	CcSEcCtD
Temozolomide—Dyspnoea—Hydroxyurea—head and neck cancer	0.000226	0.00238	CcSEcCtD
Temozolomide—Somnolence—Hydroxyurea—head and neck cancer	0.000226	0.00238	CcSEcCtD
Temozolomide—Erythema—Fluorouracil—head and neck cancer	0.000224	0.00236	CcSEcCtD
Temozolomide—Dyspepsia—Hydroxyurea—head and neck cancer	0.000224	0.00235	CcSEcCtD
Temozolomide—Decreased appetite—Hydroxyurea—head and neck cancer	0.000221	0.00233	CcSEcCtD
Temozolomide—Pancytopenia—Docetaxel—head and neck cancer	0.00022	0.00232	CcSEcCtD
Temozolomide—Abdominal pain—Vinblastine—head and neck cancer	0.00022	0.00232	CcSEcCtD
Temozolomide—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.000219	0.00231	CcSEcCtD
Temozolomide—Fatigue—Hydroxyurea—head and neck cancer	0.000219	0.00231	CcSEcCtD
Temozolomide—Constipation—Hydroxyurea—head and neck cancer	0.000217	0.00229	CcSEcCtD
Temozolomide—Pain—Hydroxyurea—head and neck cancer	0.000217	0.00229	CcSEcCtD
Temozolomide—Neutropenia—Docetaxel—head and neck cancer	0.000217	0.00229	CcSEcCtD
Temozolomide—Weight increased—Docetaxel—head and neck cancer	0.000211	0.00222	CcSEcCtD
Temozolomide—Vision blurred—Fluorouracil—head and neck cancer	0.000211	0.00222	CcSEcCtD
Temozolomide—Weight decreased—Docetaxel—head and neck cancer	0.00021	0.00221	CcSEcCtD
Temozolomide—Feeling abnormal—Hydroxyurea—head and neck cancer	0.000209	0.0022	CcSEcCtD
Temozolomide—Pneumonia—Docetaxel—head and neck cancer	0.000208	0.00219	CcSEcCtD
Temozolomide—Anaemia—Fluorouracil—head and neck cancer	0.000207	0.00218	CcSEcCtD
Temozolomide—Infestation NOS—Docetaxel—head and neck cancer	0.000207	0.00218	CcSEcCtD
Temozolomide—Infestation—Docetaxel—head and neck cancer	0.000207	0.00218	CcSEcCtD
Temozolomide—Hypersensitivity—Vinblastine—head and neck cancer	0.000205	0.00216	CcSEcCtD
Temozolomide—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.000205	0.00216	CcSEcCtD
Temozolomide—Neuropathy peripheral—Docetaxel—head and neck cancer	0.000203	0.00214	CcSEcCtD
Temozolomide—Stomatitis—Docetaxel—head and neck cancer	0.000202	0.00212	CcSEcCtD
Temozolomide—Body temperature increased—Hydroxyurea—head and neck cancer	0.000201	0.00211	CcSEcCtD
Temozolomide—Leukopenia—Fluorouracil—head and neck cancer	0.0002	0.00211	CcSEcCtD
Temozolomide—Asthenia—Vinblastine—head and neck cancer	0.0002	0.0021	CcSEcCtD
Temozolomide—Hepatobiliary disease—Docetaxel—head and neck cancer	0.000196	0.00206	CcSEcCtD
Temozolomide—Convulsion—Fluorouracil—head and neck cancer	0.000194	0.00204	CcSEcCtD
Temozolomide—Myalgia—Fluorouracil—head and neck cancer	0.000191	0.00201	CcSEcCtD
Temozolomide—Diarrhoea—Vinblastine—head and neck cancer	0.000191	0.00201	CcSEcCtD
Temozolomide—Discomfort—Fluorouracil—head and neck cancer	0.000188	0.00198	CcSEcCtD
Temozolomide—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000187	0.00197	CcSEcCtD
Temozolomide—Haemoglobin—Docetaxel—head and neck cancer	0.000187	0.00197	CcSEcCtD
Temozolomide—Haemorrhage—Docetaxel—head and neck cancer	0.000186	0.00196	CcSEcCtD
Temozolomide—Hepatitis—Docetaxel—head and neck cancer	0.000186	0.00196	CcSEcCtD
Temozolomide—Hypoaesthesia—Docetaxel—head and neck cancer	0.000185	0.00195	CcSEcCtD
Temozolomide—Confusional state—Fluorouracil—head and neck cancer	0.000184	0.00194	CcSEcCtD
Temozolomide—Pharyngitis—Docetaxel—head and neck cancer	0.000184	0.00194	CcSEcCtD
Temozolomide—Dizziness—Vinblastine—head and neck cancer	0.000184	0.00194	CcSEcCtD
Temozolomide—Urinary tract disorder—Docetaxel—head and neck cancer	0.000183	0.00193	CcSEcCtD
Temozolomide—Oedema peripheral—Docetaxel—head and neck cancer	0.000183	0.00193	CcSEcCtD
Temozolomide—Anaphylactic shock—Fluorouracil—head and neck cancer	0.000183	0.00193	CcSEcCtD
Temozolomide—Oedema—Fluorouracil—head and neck cancer	0.000183	0.00193	CcSEcCtD
Temozolomide—Connective tissue disorder—Docetaxel—head and neck cancer	0.000182	0.00192	CcSEcCtD
Temozolomide—Asthenia—Hydroxyurea—head and neck cancer	0.000182	0.00192	CcSEcCtD
Temozolomide—Urethral disorder—Docetaxel—head and neck cancer	0.000182	0.00192	CcSEcCtD
Temozolomide—Infection—Fluorouracil—head and neck cancer	0.000182	0.00191	CcSEcCtD
Temozolomide—Nervous system disorder—Fluorouracil—head and neck cancer	0.000179	0.00189	CcSEcCtD
Temozolomide—Thrombocytopenia—Fluorouracil—head and neck cancer	0.000179	0.00189	CcSEcCtD
Temozolomide—Visual impairment—Docetaxel—head and neck cancer	0.000179	0.00189	CcSEcCtD
Temozolomide—Vomiting—Vinblastine—head and neck cancer	0.000177	0.00187	CcSEcCtD
Temozolomide—Erythema multiforme—Docetaxel—head and neck cancer	0.000176	0.00185	CcSEcCtD
Temozolomide—Headache—Vinblastine—head and neck cancer	0.000174	0.00184	CcSEcCtD
Temozolomide—Anorexia—Fluorouracil—head and neck cancer	0.000174	0.00184	CcSEcCtD
Temozolomide—Diarrhoea—Hydroxyurea—head and neck cancer	0.000174	0.00183	CcSEcCtD
Temozolomide—Eye disorder—Docetaxel—head and neck cancer	0.000174	0.00183	CcSEcCtD
Temozolomide—Cardiac disorder—Docetaxel—head and neck cancer	0.000172	0.00182	CcSEcCtD
Temozolomide—Flushing—Docetaxel—head and neck cancer	0.000172	0.00182	CcSEcCtD
Temozolomide—Angiopathy—Docetaxel—head and neck cancer	0.000168	0.00177	CcSEcCtD
Temozolomide—Dizziness—Hydroxyurea—head and neck cancer	0.000168	0.00177	CcSEcCtD
Temozolomide—Immune system disorder—Docetaxel—head and neck cancer	0.000168	0.00177	CcSEcCtD
Temozolomide—Mediastinal disorder—Docetaxel—head and neck cancer	0.000167	0.00176	CcSEcCtD
Temozolomide—Chills—Docetaxel—head and neck cancer	0.000167	0.00176	CcSEcCtD
Temozolomide—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000167	0.00175	CcSEcCtD
Temozolomide—Nausea—Vinblastine—head and neck cancer	0.000165	0.00174	CcSEcCtD
Temozolomide—Insomnia—Fluorouracil—head and neck cancer	0.000165	0.00174	CcSEcCtD
Temozolomide—Paraesthesia—Fluorouracil—head and neck cancer	0.000164	0.00173	CcSEcCtD
Temozolomide—Alopecia—Docetaxel—head and neck cancer	0.000164	0.00173	CcSEcCtD
Temozolomide—Dyspnoea—Fluorouracil—head and neck cancer	0.000163	0.00172	CcSEcCtD
Temozolomide—Mental disorder—Docetaxel—head and neck cancer	0.000163	0.00171	CcSEcCtD
Temozolomide—Somnolence—Fluorouracil—head and neck cancer	0.000162	0.00171	CcSEcCtD
Temozolomide—Erythema—Docetaxel—head and neck cancer	0.000162	0.0017	CcSEcCtD
Temozolomide—Malnutrition—Docetaxel—head and neck cancer	0.000162	0.0017	CcSEcCtD
Temozolomide—Vomiting—Hydroxyurea—head and neck cancer	0.000161	0.0017	CcSEcCtD
Temozolomide—Dyspepsia—Fluorouracil—head and neck cancer	0.000161	0.00169	CcSEcCtD
Temozolomide—Rash—Hydroxyurea—head and neck cancer	0.00016	0.00169	CcSEcCtD
Temozolomide—Dermatitis—Hydroxyurea—head and neck cancer	0.00016	0.00169	CcSEcCtD
Temozolomide—Headache—Hydroxyurea—head and neck cancer	0.000159	0.00168	CcSEcCtD
Temozolomide—Decreased appetite—Fluorouracil—head and neck cancer	0.000159	0.00167	CcSEcCtD
Temozolomide—Dysgeusia—Docetaxel—head and neck cancer	0.000158	0.00167	CcSEcCtD
Temozolomide—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000158	0.00166	CcSEcCtD
Temozolomide—Back pain—Docetaxel—head and neck cancer	0.000156	0.00165	CcSEcCtD
Temozolomide—Pain—Fluorouracil—head and neck cancer	0.000156	0.00165	CcSEcCtD
Temozolomide—Nausea—Hydroxyurea—head and neck cancer	0.000151	0.00159	CcSEcCtD
Temozolomide—Feeling abnormal—Fluorouracil—head and neck cancer	0.000151	0.00159	CcSEcCtD
Temozolomide—Anaemia—Docetaxel—head and neck cancer	0.000149	0.00157	CcSEcCtD
Temozolomide—Urticaria—Fluorouracil—head and neck cancer	0.000145	0.00153	CcSEcCtD
Temozolomide—Leukopenia—Docetaxel—head and neck cancer	0.000145	0.00152	CcSEcCtD
Temozolomide—Body temperature increased—Fluorouracil—head and neck cancer	0.000144	0.00152	CcSEcCtD
Temozolomide—Palpitations—Docetaxel—head and neck cancer	0.000143	0.0015	CcSEcCtD
Temozolomide—Cough—Docetaxel—head and neck cancer	0.000141	0.00149	CcSEcCtD
Temozolomide—Convulsion—Docetaxel—head and neck cancer	0.00014	0.00148	CcSEcCtD
Temozolomide—Hypertension—Docetaxel—head and neck cancer	0.00014	0.00147	CcSEcCtD
Temozolomide—Arthralgia—Docetaxel—head and neck cancer	0.000138	0.00145	CcSEcCtD
Temozolomide—Myalgia—Docetaxel—head and neck cancer	0.000138	0.00145	CcSEcCtD
Temozolomide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000137	0.00144	CcSEcCtD
Temozolomide—Hypersensitivity—Fluorouracil—head and neck cancer	0.000135	0.00142	CcSEcCtD
Temozolomide—Dry mouth—Docetaxel—head and neck cancer	0.000135	0.00142	CcSEcCtD
Temozolomide—Confusional state—Docetaxel—head and neck cancer	0.000133	0.0014	CcSEcCtD
Temozolomide—Anaphylactic shock—Docetaxel—head and neck cancer	0.000132	0.00139	CcSEcCtD
Temozolomide—Oedema—Docetaxel—head and neck cancer	0.000132	0.00139	CcSEcCtD
Temozolomide—Infection—Docetaxel—head and neck cancer	0.000131	0.00138	CcSEcCtD
Temozolomide—Nervous system disorder—Docetaxel—head and neck cancer	0.000129	0.00136	CcSEcCtD
Temozolomide—Pruritus—Fluorouracil—head and neck cancer	0.000129	0.00136	CcSEcCtD
Temozolomide—Thrombocytopenia—Docetaxel—head and neck cancer	0.000129	0.00136	CcSEcCtD
Temozolomide—Skin disorder—Docetaxel—head and neck cancer	0.000128	0.00135	CcSEcCtD
Temozolomide—Anorexia—Docetaxel—head and neck cancer	0.000126	0.00132	CcSEcCtD
Temozolomide—Diarrhoea—Fluorouracil—head and neck cancer	0.000125	0.00132	CcSEcCtD
Temozolomide—Dizziness—Fluorouracil—head and neck cancer	0.000121	0.00127	CcSEcCtD
Temozolomide—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.00012	0.00127	CcSEcCtD
Temozolomide—Insomnia—Docetaxel—head and neck cancer	0.000119	0.00126	CcSEcCtD
Temozolomide—Paraesthesia—Docetaxel—head and neck cancer	0.000118	0.00125	CcSEcCtD
Temozolomide—Dyspnoea—Docetaxel—head and neck cancer	0.000118	0.00124	CcSEcCtD
Temozolomide—Somnolence—Docetaxel—head and neck cancer	0.000117	0.00124	CcSEcCtD
Temozolomide—Vomiting—Fluorouracil—head and neck cancer	0.000116	0.00122	CcSEcCtD
Temozolomide—Dyspepsia—Docetaxel—head and neck cancer	0.000116	0.00122	CcSEcCtD
Temozolomide—Rash—Fluorouracil—head and neck cancer	0.000115	0.00121	CcSEcCtD
Temozolomide—Dermatitis—Fluorouracil—head and neck cancer	0.000115	0.00121	CcSEcCtD
Temozolomide—Decreased appetite—Docetaxel—head and neck cancer	0.000115	0.00121	CcSEcCtD
Temozolomide—Headache—Fluorouracil—head and neck cancer	0.000115	0.00121	CcSEcCtD
Temozolomide—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000114	0.0012	CcSEcCtD
Temozolomide—Fatigue—Docetaxel—head and neck cancer	0.000114	0.0012	CcSEcCtD
Temozolomide—Pain—Docetaxel—head and neck cancer	0.000113	0.00119	CcSEcCtD
Temozolomide—Constipation—Docetaxel—head and neck cancer	0.000113	0.00119	CcSEcCtD
Temozolomide—Feeling abnormal—Docetaxel—head and neck cancer	0.000109	0.00115	CcSEcCtD
Temozolomide—Nausea—Fluorouracil—head and neck cancer	0.000109	0.00114	CcSEcCtD
Temozolomide—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000108	0.00114	CcSEcCtD
Temozolomide—Body temperature increased—Docetaxel—head and neck cancer	0.000104	0.0011	CcSEcCtD
Temozolomide—Abdominal pain—Docetaxel—head and neck cancer	0.000104	0.0011	CcSEcCtD
Temozolomide—Hypersensitivity—Docetaxel—head and neck cancer	9.72e-05	0.00102	CcSEcCtD
Temozolomide—Asthenia—Docetaxel—head and neck cancer	9.46e-05	0.000997	CcSEcCtD
Temozolomide—Pruritus—Docetaxel—head and neck cancer	9.33e-05	0.000983	CcSEcCtD
Temozolomide—Diarrhoea—Docetaxel—head and neck cancer	9.03e-05	0.000951	CcSEcCtD
Temozolomide—Dizziness—Docetaxel—head and neck cancer	8.72e-05	0.000919	CcSEcCtD
Temozolomide—Vomiting—Docetaxel—head and neck cancer	8.39e-05	0.000884	CcSEcCtD
Temozolomide—Rash—Docetaxel—head and neck cancer	8.32e-05	0.000876	CcSEcCtD
Temozolomide—Dermatitis—Docetaxel—head and neck cancer	8.31e-05	0.000875	CcSEcCtD
Temozolomide—Headache—Docetaxel—head and neck cancer	8.26e-05	0.000871	CcSEcCtD
Temozolomide—Nausea—Docetaxel—head and neck cancer	7.84e-05	0.000825	CcSEcCtD
